4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-035034
Director acquired 7,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Molineaux Christopher P. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-06 | Exercise or conversion : show line 1 in the form | +7,333 | 23,891 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-04 | Grant or award : show line 2 in the form Option Grant (right to buy) | +16,500 | 16,500 | D |
| 2020-06-06 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −7,333 | 0 | D |
Loading xslF345X03/doc4.xml…